GlobeNewswire by notified

Boreo Plc new shares registered to trade register

Share

Boreo Plc         Stock exchange release       5 January 2023 at 17:00 EET

Boreo Plc new shares registered to trade register

Boreo Plc announced on 2 January 2023, that it had completed the acquisition of Filterit Oy and executes a directed share issuance of 9 645 new shares to the sellers as part of the fixed payment. The new shares subscribed have been registered into the Finnish Trade Register today, on 5 January 2023.  After the registration of the new shares, the company will have 2 701 353 shares in total. 

The new shares produce the shareholder rights as of the registration date to Euroclear Finland Ltd book-entry system, on about 9 January 2023. The new shares will be admitted to trading on the official list of Nasdaq Helsinki Ltd on about 9 January 2023.

Vantaa, 5 January 2023

Boreo Plc
Kari Nerg
CEO

Distribution:
NASDAQ Helsinki Ltd
Principal media
www.boreo.com

For more information:
CEO Kari Nerg
+358 44 341 8514

CFO Aku Rumpunen
+358 40 5563546

Boreo in brief:

Boreo is a company listed on Nasdaq Helsinki that creates value by owning, acquiring and developing small and medium sized companies in Northern Europe. Boreo's business operations are organized into three business areas: Electronics, Technical Trade and Heavy Machines.

Boreo’s main objective is to create shareholder value in the long-term. It aims to achieve this with an acquisition-driven strategy, creating optimal conditions for its businesses to increase sales and improve profitability, and by being a best-in-class home for its companies and personnel. ​

The Group's net sales in 2021 were EUR 122 million and it employs some 300 people in seven countries. The company’s headquarter is in Vantaa.


To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Cozycozy is the Only Accommodation Search Engine That Now Includes Airbnb, Giving Travelers the Largest Selection of Vacation Rentals Possible30.1.2023 14:30:00 CET | Press release

One search, so many possibilities - cozycozy helps users find their perfect holiday accommodation from over 100+ booking platforms, including Airbnb. NEW YORK, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Cozycozy knows that finding the perfect place to stay can be hard. With the rise of so many vacation rental and hotel platforms comes more and more options, overwhelming travelers. "The days of having multiple tabs open to find the best deal are over," says Romain Claudel, co-founder of cozycozy. "We created cozycozy.com so travelers can see all their options in one place, without all the hassle." There are more and more vacation rentals and hotel rooms listed on several platforms, often with rates that vary. By using cozycozy, users conveniently get the lowest price possible. Their website allows users to see a comprehensive list of available options all at once, so that they get the best rates. They are the only platform in the world to include Airbnb in its search engines, letting users compa

Bank of Åland Plc: Managers' Transactions (Johansson)30.1.2023 14:30:00 CET | Press release

Bank of Åland Plc Managers' Transactions January 30, 2023, 15.30 EET Managers' Transactions --- Person subject to the notification requirement Name: Magnus Johannsson Position: Other senior manager Issuer: Ålandsbanken Abp LEI: 7437006WYM821IJ3MN73 Notification type: INITIAL NOTIFICATION Reference number: 24871/4/4 --- Transaction date: 2023-01-25 Outside a trading venue Instrument type: SHARE ISIN: FI0009001127 Nature of transaction: SUBSCRIPTION Transaction details (1): Volume: 233 Unit price: 32.98 EUR Aggregated transactions (1): Volume: 233 Volume weighted average price: 32.98 EUR For further information, please contact: Peter Wiklöf, Managing Director and Chief Executive, tel +358 40 512 7505

Ålandsbanken Abp: Transaktioner utförda av personer i ledande ställning (Johansson)30.1.2023 14:30:00 CET | Pressemelding

Ålandsbanken Abp Transaktioner utförda av personer i ledande ställning 30.1.2023 kl. 15.30 EET Transaktioner utförda av personer i ledande ställning --- Den anmälningsskyldiga Namn: Magnus Johannsson Befattning: Annan person i högsta ledningen Emittent: Ålandsbanken Abp LEI: 7437006WYM821IJ3MN73 Anmälans karaktär: FÖRSTA ANMÄLAN Referensnummer: 24871/4/4 --- Transaktionens datum: 2023-01-25 Utanför en handelsplats Instrument typ: AKTIE ISIN: FI0009001127 Transaktionens karaktär: TECKNING Detaljer om transaktionerna (1): Volym: 233 Enhetspris: 32.98 EUR Aggregerad information om transaktionerna (1): Volym: 233 Medelpris: 32.98 EUR Ytterligare information: Peter Wiklöf, Vd och koncernchef, Ålandsbanken Abp, tfn +358 40 512 7505

Junshi Biosciences Announces Approval for Marketing of VV116 in China30.1.2023 14:24:07 CET | Press release

SHANGHAI, China, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the National Medical Products Administration (the “NMPA”) has conducted urgent review and approval under Special Examination and Approval of Drugs, and conditionally approved for marketing Deuremidevir Hydrobromide Tablets (project code: JT001/VV116, “VV116”), an oral nucleoside analog anti-SARS-CoV-2 drug, for the treatment of adult patients with mild to moderate coronavirus disease 2019 (“COVID-19”). VV116 is a new oral nucleoside analog antiviral drug, which can be non-covalently bound to the active center of RNA-dependent RNA polymerase (“RdRp”) of SARS-CoV-2 in the form of nucleoside triphosphate, directly inhibiting the activity of RdRp of the virus and blocking the replication of virus, th

Sectigo Announces Automation of AWS and Google Cloud Platform Certificates With Sectigo Certificate Manager30.1.2023 14:00:00 CET | Press release

Leading Public Cloud Certificate Providers Join Sectigo’s Broad Ecosystem of Support Including Microsoft ADCS, Public CAs, and Other Leading Technology Integrations ROSELAND, N.J., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Sectigo, a global leader in automated Certificate Lifecycle Management (CLM) and digital certificates, today announced the latest expansion to its industry-leading CLM ecosystem, via Sectigo Certificate Manager (SCM). Organizations can now seamlessly issue and manage digital certificates originating from Google Cloud Platform (GCP), AWS Cloud Services, as well as publicly trusted CAs, providing complete visibility and lifecycle control over all public and private digital certificates within a single platform. This functionality builds upon Sectigo’s already robust capability and enables enterprises to discover, deploy, install, and renew the lifecycles of all digital certificates deployed within an enterprise ecosystem. These additional integrations further deliver on Sectig